DC Vaccine Combined With CIK Cells in Patients With SCLC

NCT02688673 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Small- Cell Lung Cancer

Interventions

BIOLOGICAL: adenovirus-transfected autologous DC vaccine plus CIK cells

Sponsor

Affiliated Hospital to Academy of Military Medical Sciences